{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:34:54Z","timestamp":1787578494946,"version":"build-2736575974"},"reference-count":108,"publisher":"Informa UK Limited","issue":"4","funder":[{"name":"not been funded"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2018,3,4]]},"DOI":"10.1080\/14656566.2018.1438408","type":"journal-article","created":{"date-parts":[[2018,2,7]],"date-time":"2018-02-07T11:39:13Z","timestamp":1518003553000},"page":"397-408","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":24,"title":["Novel pharmacotherapy for the treatment of hospital-acquired and ventilator-associated pneumonia caused by resistant gram-negative bacteria"],"prefix":"10.1080","volume":"19","author":[{"given":"James M.","family":"Kidd","sequence":"first","affiliation":[{"name":"Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph L.","family":"Kuti","sequence":"additional","affiliation":[{"name":"Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Nicolau","sequence":"additional","affiliation":[{"name":"Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2018,2,19]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-001-1143-z"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1086\/432803"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2008.02.001"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02636-14"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofx176"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw353"},{"issue":"10","key":"CIT0007","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/jhm.2080","volume":"8","author":"Zilberberg MD","year":"2013","journal-title":"J Hosp Med"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2014.914172"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis552"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2013.12.009"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003126"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00510-13"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir934"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1186\/cc3995"},{"key":"CIT0015","unstructured":"Zavicefta assessment report. London: European Medicines Agency Committee for Medicinal Products for Human Use; 2016. (Procedure No. EMEA\/H\/C\/004027\/0000)."},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1622"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00989-17"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01585-15"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02429-13"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02161-13"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.04627-14"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03267-14"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv170"},{"key":"CIT0024","volume-title":"Poster session presented at: PK\/PD of antibiotics against Gram-negatives. 24th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)","author":"Li J","year":"2014"},{"key":"CIT0025","volume-title":"Poster session presented at: Clinical study with new antibiotics and antifungals","author":"Torres A","year":"2017"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix783"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2016.11.005"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-013-0168-2"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2014.01.032"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00875-17"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks343"},{"key":"CIT0032","volume-title":"Zerbaxa [package insert]","year":"2016"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01590-12"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03572-14"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02513-12"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks246"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.566"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix014"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ411"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02608-15"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2016.06.005"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02136-16"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00567-17"},{"issue":"10","key":"CIT0044","first-page":"e00989","volume":"61","author":"Lomovskaya O","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00711-16"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00568-16"},{"key":"CIT0047","volume-title":"Poster session presented at: New antibacterial drugs. 25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)","author":"Tarazi Z","year":"2014"},{"key":"CIT0048","volume-title":"54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)","author":"Sabet M","year":"2015"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01713-15"},{"key":"CIT0050","volume-title":"Vabomere [package insert]","year":"2017"},{"key":"CIT0051","volume-title":"Poster presented at: IDWeek","author":"Kaye KS","year":"2017"},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.1016\/j.mib.2010.09.004"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.1586\/eri.12.25"},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq408"},{"key":"CIT0055","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02744-13"},{"key":"CIT0056","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2015.07.021"},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofx163.1202"},{"key":"CIT0058","volume-title":"Presented at: ASM Microbe","author":"Connolly LE","year":"2017"},{"issue":"12","key":"CIT0059","doi-asserted-by":"crossref","first-page":"7396","DOI":"10.1128\/AAC.01405-16","volume":"60","author":"Ito A","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"CIT0060","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03098-15"},{"key":"CIT0061","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-017-3063-z"},{"key":"CIT0062","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01022-17"},{"key":"CIT0063","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00700-17"},{"key":"CIT0064","volume-title":"Poster presented at: clinical study with new anbitiotics and antifungals","author":"Portsmouth S","year":"2017"},{"key":"CIT0065","unstructured":"Clinical study of S-649266 for the treatment of nosocomial pneumonia caused by Gram-negative pathogens (APEKS-NP) [Internet]. Identifier NCT03032380. Bethesda (MD): National Library of Medicine; [cited 2017 Nov 30]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03032380"},{"key":"CIT0066","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2013.12.101"},{"key":"CIT0067","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02209-16"},{"key":"CIT0068","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.05927-11"},{"key":"CIT0069","unstructured":"Study of the safety, tolerability, and efficacy of MK-7655 + imipenem\/cilastatin versus imipenem\/cilastatin alone to treat complicated intra-abdominal infection [cIAI] (MK-7655-004) [Internet]. Identifier NCT01505634. Bethesda (MD): National Library of Medicine; [cited 2017 Nov 30]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01506271"},{"key":"CIT0070","unstructured":"Study of the safety, tolerability, and efficacy of MK-7655 + imipenem\/cilastatin versus imipenem\/cilastatin alone for the treatment of complicated urinary tract infection (cUTI) (MK-7655-003) [Internet]. Identifier NCT01505634. Bethesda (MD): National Library of Medicine; [cited 2017 Nov 30]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01505634"},{"key":"CIT0071","unstructured":"Efficacy and safety of imipenem+cilastatin\/relebactam (MK-7655A) versus colistimethate sodium + imipenem+cilastatin in imipenem-tesistant bacterial infection (MK-7655A-013) (RESTORE-IMI 1) [Internet]. Identifier NCT02452047. Bethesda (MD): National Library of Medicine; [cited 2017 Nov 30]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02452047"},{"key":"CIT0072","unstructured":"Imipenem\/relebactam\/cilastatin versus piperacillin\/tazobactam for treatment of participants with bacterial pneumonia (MK-7655A-014) (RESTORE-IMI 2) [Internet]. Identifier NCT02452047. Bethesda (MD): National Library of Medicine; [cited 2017 Nov 30]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02493764"},{"key":"CIT0073","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00068-15"},{"key":"CIT0074","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv221"},{"key":"CIT0075","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.03484-13"},{"key":"CIT0076","volume-title":"Breakpoint tables for interpretation of MICs and zone diameters","author":"The European Committee on Antimicrobial Susceptibility Testing","year":"2017"},{"key":"CIT0077","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr466"},{"key":"CIT0078","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv221"},{"key":"CIT0079","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq070"},{"key":"CIT0080","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2016.12.005"},{"key":"CIT0081","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2017.4046"},{"key":"CIT0082","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2013.09.010"},{"key":"CIT0083","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-016-0140-x"},{"key":"CIT0084","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00582-2017"},{"key":"CIT0085","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000001570"},{"key":"CIT0086","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2017.03.018"},{"key":"CIT0087","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201311-395FR"},{"key":"CIT0088","doi-asserted-by":"publisher","DOI":"10.1089\/jamp.2013.1100"},{"key":"CIT0089","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02780-13"},{"key":"CIT0090","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01763-16"},{"key":"CIT0091","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02779-13"},{"key":"CIT0092","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2016.11.026"},{"key":"CIT0093","doi-asserted-by":"publisher","DOI":"10.1586\/17434440.5.1.9"},{"key":"CIT0094","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-011-2420-0"},{"key":"CIT0095","doi-asserted-by":"publisher","DOI":"10.1186\/s12941-016-0155-z"},{"key":"CIT0096","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2015.07.010"},{"key":"CIT0097","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv370"},{"key":"CIT0098","doi-asserted-by":"publisher","DOI":"10.1080\/23744235.2017.1356933"},{"key":"CIT0099","unstructured":"Inhaled amikacin solution BAY41-6551 as Adjunctive Therapy in the Treatment of Gram-Negative Pneumonia (INHALE 1) [Internet]. Identifier NCT01799993. Bethesda (MD): National Library of Medicine; [cited 2017 Nov 30]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01799993"},{"key":"CIT0100","unstructured":"Inhaled amikacin solution BAY41-6551 as Adjunctive Therapy in the Treatment of Gram-Negative Pneumonia (INHALE 2) [Internet]. Identifier NCT00805168. Bethesda (MD): National Library of Medicine; [cited 2017 30 Nov]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00805168"},{"key":"CIT0101","volume-title":"Phase III study with Amikacin Inhale in intubated and mechanically ventilated patients with Gram-negative pneumonia does not meet primary endpoint of superiority [Internet]","year":"2017"},{"key":"CIT0102","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr466"},{"key":"CIT0103","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.05041-11"},{"key":"CIT0104","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.3.650"},{"key":"CIT0105","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00777-17"},{"key":"CIT0106","doi-asserted-by":"publisher","DOI":"10.1021\/acsinfecdis.7b00243"},{"key":"CIT0107","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00436-16"},{"key":"CIT0108","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2016.4237"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2018.1438408","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T00:48:24Z","timestamp":1660438104000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2018.1438408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,19]]},"references-count":108,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,3,4]]}},"alternative-id":["10.1080\/14656566.2018.1438408"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2018.1438408","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,19]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2017-12-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-02-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-02-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}